Benjamin Zohar, NCACIP

The Global ADHD Medication Shortage Is Fueling a Hidden Overdose Crisis

Benjamin Zohar, NCACIP -
Infographic: The ADHD medication shortage fuels an overdose crisis. 7 in 10 counterfeit pills contain lethal fentanyl doses, 60 million pills seized in 2024, 59% of overdoses involve stimulants, shortage ongoing for 3 years globally. By Benjamin Zohar, NCACIP for ISSUP.
The ADHD medication shortage entering its third year is pushing patients toward unregulated markets where counterfeit pills laced with fentanyl have become ubiquitous. DEA testing shows 7 out of 10 seized pills contain lethal doses.
Benjamin Zohar, NCACIP

DEA Adjusts Stimulant Production Quotas Amid Ongoing ADHD Medication Shortages in 2025

Benjamin Zohar, NCACIP -
the 2025 ADHD shortage continues—driven by deeper manufacturing and distribution issues
Despite DEA efforts to raise production quotas for stimulant medications, the 2025 ADHD shortage continues—driven by deeper manufacturing and distribution issues. Ongoing oversight from agencies like the FDA, DEA, and ASHP is critical, but families and providers still face real-time access challenges. Clearer supply chain policies and responsive pharmacy data could help prevent future disruptions.
Benjamin Zohar, NCACIP

2025 ADHD Stimulant Shortage: Patient & Provider Guidance

Benjamin Zohar, NCACIP -
Benjamin Zohar, NCACIP is an addiction intervention professional specializing in international systems, crisis navigation, and clinical-policy translation.
Stimulant medications, including Adderall, remain in active shortage across multiple regions in 2025, affecting treatment stability and increasing counterfeit-pill risks. This article explains the latest data behind the shortage and outlines safe, practical steps patients and professionals can take when prescriptions are unavailable.
Benjamin Zohar, NCACIP

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Benjamin Zohar, NCACIP -
Benjamin Zohar Adderall interventionist New York

The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals

Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of InterventionNY

This article is intended for education and professional development and does not replace individualized medical, psychiatric, or pharmaceutical consultation.

Summary

The 2025 global shortage of Adderall and related stimulant medications is affecting patient stability, treatment continuity, and public health systems across multiple regions. Driven...

Benjamin Zohar, NCACIP

Best Rehabs in Long Island, NY: A Comprehensive Guide to Recovery Resources

Benjamin Zohar, NCACIP -

🏥 Best Rehabs in Long Island, NY: Your Complete Guide to Recovery

Author: Benjamin Zohar, NCACIP (Addiction Professional) | Published: November 22, 2025 | Category: Treatment Resources & Recovery Support

🌟 Finding the right addiction treatment center can be a life-changing decision. Long Island, New York, offers a diverse range of rehabilitation facilities that provide evidence-based care for individuals struggling with substance use disorders. This comprehensive guide explores the best rehabs in Long Island, helping you or your loved ones navigate the path to recovery with confidence and...

Upcoming Events

There aren't any upcoming events
Contact Us

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy